Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Thirty Parkinson's disease (PD) patients were divided into three equal groups according to their disease duration while 10 normal healthy volunteers matched for age and sex served as a control group. Striatal and extrastriatal serotonergic function was studied with (11)C-DASB PET, a marker of serotonin transporter availability. (11)C-DASB binding was correlated with disease disability and exposure to dopaminergic therapy. We found significant (11)C-DASB binding reductions in striatal, brainstem, and cortical regions in PD but no correlations were evident between (11)C-DASB binding and UPDRS scores, Hoehn &Yahr staging, disease duration and level of exposure to dopaminergic therapy. Our results suggest that progressive non-linear serotonergic dysfunction occurs in PD but it does not determine levels of disability. Additionally, chronic exposure to dopaminergic therapy does not appear to influence SERT binding.

Original publication

DOI

10.1016/j.nbd.2010.05.028

Type

Journal article

Journal

Neurobiol Dis

Publication Date

10/2010

Volume

40

Pages

216 - 221

Keywords

Adult, Aged, Benzylamines, Carbon Radioisotopes, Female, Humans, Male, Middle Aged, Parkinson Disease, Positron-Emission Tomography, Predictive Value of Tests, Sensitivity and Specificity, Serotonin, Severity of Illness Index